Guiding Strategic Excellence for Life Sciences Companies
Custom Consulting Solutions From Early Stage Biotechnology to Established Pharmaceutical Players
PROJECT TYPES
Nublar is a premier thought partner, collaborator, and operational guide for addressing strategic challenges and opportunities in the life sciences industry.
By leveraging vast experience establishing, running, and advising companies focused on drug development and life cycle management, we provide our clients with best-fit solutions to win in today's ultra competitive and dynamic market. Our goal is to understand the problem you need to solve, and create a custom solution informed by our technical and commercial expertise.
Our engagements are diverse, ranging from disease area landscape assessment to product launch strategy, and many other initiatives driving value for biopharma companies regardless of size or stage.
-
Disease Area Landscape | Within a given therapeutic area and disease indication, Nublar provides a comprehensive understanding of the underlying biology, standard of care, unmet clinical needs, ongoing clinical development programs, and key competitors
-
Competitive Analysis | Nublar provides in depth comparison of specific pipeline or post-approval products according to a proprietary matrix approach that includes parameters such as differentiation on biochemical properties, mechanism of action, efficacy and safety profile, opinion leader views, clinical benchmarks, head-to-head SWOT analysis, and implications for existing or investigational product development / positioning
-
TPP Development | Leveraging elements of competitive analysis and disease landscapes, Nublar assists in developing an ideal target product profile according to known clinical metrics and desired properties, but also engages with external thought leaders to understand additional features of potential differentiation
-
Stakeholder Insights | Nublar's strategic guidance is informed though existing internal knowledge in biological sciences, however we are continually revising the evaluation of existing treatment paradigms, reactions to clinical trial readouts, perspectives on specific drugs or drug modalities, likelihood of product success and uptake, and optimal positioning within and across disease indications to help clients arrive at conclusions based on views from the 'end-user' clinical decision makers
-
Competitive Intelligence | At the core of our recommendations is awareness of the latest development, catalysts, clinical trial and program announcements, and corporate communications, which we provide to clients according to their needs for level and frequency of updates
-
Market Insights and Process | We help our clients understand new and familiar markets through sizing, major and minor player identification and characterization, region-specific strategic considerations, customer / user profiling, buying process, detailed product description and differentiation, and manufacturing variables
-
Pricing & Market Access | Even at the early stages of development, we help guide clients through the various checkpoints for evidence gathering, clinical endpoint benchmarking, cost-effectiveness analyses, addressable market sizing, and more to support the pathway to marketing authorization, pricing discussions, and eventual agreements to bring approved drugs to market under reimbursement systems that vary widely across countries and regions
-
Market Trends and Opportunities | Nublar is continually developing internal perspectives on how expected market events will impact the drug development landscape to bring better therapeutic options to patients, including better diagnostics and testing, patient advocacy partnerships, and improving patient-centric quality of life; Nublar helps clients contextualize these market trends into actionable insights and opportunities to be leaders in a given disease or across therapeutic areas and emerging technology spaces